Condition: Biochemically Recurrent Prostate Carcinoma · Oligometastatic Prostate Carcinoma · Recurrent Prostate Adenocarcinoma · Sponsor: Mayo Clinic
This phase III trial tests the side effects of stereotactic body radiation therapy (SBRT) compared to hypofractionated radiotherapy for treating patients with prostate adenocarcinoma that has come back after a period of improvement (recurrent) or that has spread from where it first started (primary site) to a limited number of sites (oligometastatic). SBRT is a type of external radiation therapy that uses special equipment to position a patient and precisely deliver radiation to tumors in the body (except the brain). The total dose of radiation is divided into smaller doses given over several days. This type of radiation therapy helps spare normal tissue. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may kill more tumors cells and have fewer side effects. SBRT may work just as well as hypofractionated radiation therapy at treating patients with biochemically recurrent or oligometastatic prostate cancer, but with a shorter treatment time and possibly fewer side effects.
This description comes directly from the study's public registry record.
Clinical Trials Referral Office · 855-776-0015 · mayocliniccancerstudies@mayo.edu
Always discuss trial participation with your own doctor first.
| Mayo Clinic in Arizona | Scottsdale, Arizona, United States | Recruiting |
| Mayo Clinic Health System in Albert Lea | Albert Lea, Minnesota, United States | Not Yet Recruiting |
| Mayo Clinic Health System - Mankato | Mankato, Minnesota, United States | Not Yet Recruiting |
| Mayo Clinic in Rochester | Rochester, Minnesota, United States | Not Yet Recruiting |
| Mayo Clinic Health System-Eau Claire Clinic | Eau Claire, Wisconsin, United States | Not Yet Recruiting |
| Mayo Clinic Health System-Franciscan Healthcare | La Crosse, Wisconsin, United States | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06205316